Trial Profile
Nusinersen Effect on Ambulatory Function of Patients with Late-onset, Chronic SMA: A Multicenter, Prospective and Retrospective Observational Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2021
Price :
$35
*
At a glance
- Drugs Nusinersen (Primary)
- Indications Spinal muscular atrophy
- Focus Therapeutic Use
- 03 Jun 2021 Status changed from active, no longer recruiting to completed.
- 26 May 2020 Status changed from recruiting to active, no longer recruiting.
- 06 Mar 2019 Status changed from not yet recruiting to recruiting.